983 Views | 932 Downloads
Email Address: Cheryl.klainman@emory.edu
Dr Klaiman carried out initial analyses, drafted the initial manuscript, and reviewed and revised the manuscript.
Dr Quintin contributed to the analyses and reviewed and revised the manuscript.
Dr Jo conducted the statistical analyses and drafted the initial Results section.
Dr Lightbody coordinated and supervised data collection at the Stanford site, conducted the initial travel study, contributed to the analyses, and reviewed and revised the manuscript.
Drs Hazlett and Piven coordinated and supervised data collection at the University of North Carolina.
Dr Hall participated in and supervised data collection at the Stanford site and critically reviewed the manuscript.
Dr Reiss conceptualized and designed the study, oversaw data collection at the Stanford site, and critically reviewed the manuscript including data analyses; and all authors approved the final manuscript as submitted.
We especially thank the many families with fragile X syndrome who devoted their precious time and energy to the project.
Dr Reiss is a consultant for Novartis and Genentech regarding fragile X syndrome. The other authors have indicated they have no financial relationships relevant to this article to disclose.
The authors have indicated they have no potential conflicts of interest to disclose.
This research was supported by National Institutes of Health grants MH064708 (Dr Reiss), MH085899 (Dr Reiss), MH050046 (Dr Reiss), MH64708 (Drs Piven and Reiss), and MH61696 (Dr Piven) and a postdoctoral grant to Dr Quintin through the Fonds Quebecois Pour la Recherche sur la Société et la Culture.
Support for this project was obtained from National Institutes of Health grants MH050047, MH064708, and MH019908, and a gift from the Canel Family Fund. Funded by the National Institutes of Health (NIH).
© 2014 by the American Academy of Pediatrics